226 related articles for article (PubMed ID: 30602374)
21. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
22. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
[TBL] [Abstract][Full Text] [Related]
23. Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.
Hamed ME; Naeem A; Alkadi H; Alamri AA; AlYami AS; AlJuryyan A; Alturaiki W; Enani M; Al-Shouli ST; Assiri AM; Alosaimi B
J Clin Immunol; 2021 Oct; 41(7):1607-1620. PubMed ID: 34232441
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
25. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
26. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
27. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.
Ajona D; Ortiz-Espinosa S; Pio R
Semin Cell Dev Biol; 2019 Jan; 85():153-163. PubMed ID: 29155219
[TBL] [Abstract][Full Text] [Related]
28. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
[TBL] [Abstract][Full Text] [Related]
29. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.
Ignatius A; Schoengraf P; Kreja L; Liedert A; Recknagel S; Kandert S; Brenner RE; Schneider M; Lambris JD; Huber-Lang M
J Cell Biochem; 2011 Sep; 112(9):2594-605. PubMed ID: 21598302
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
32. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
33. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
[TBL] [Abstract][Full Text] [Related]
34. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
[TBL] [Abstract][Full Text] [Related]
35. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.
Enskog A; Bengtsson A; Bengtson JP; Heideman M; Andreasson S; Larsson L
Eur J Pediatr; 1996 Jan; 155(1):41-5. PubMed ID: 8750809
[TBL] [Abstract][Full Text] [Related]
36. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
[TBL] [Abstract][Full Text] [Related]
37. Complement and macrophage crosstalk during process of angiogenesis in tumor progression.
Khan MA; Assiri AM; Broering DC
J Biomed Sci; 2015 Jul; 22(1):58. PubMed ID: 26198107
[TBL] [Abstract][Full Text] [Related]
38. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
40. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
